Forest Hills Lab Appoints Dr. Eddy Zhu as Chief CMC Officer
Portfolio - People | Feb 26, 2025 | EIN

Forest Hills Lab, a global life sciences company specializing in regenerative medicine and medical aesthetics, has appointed Dr. Eddy Zhu as their Chief CMC Officer. Dr. Zhu, who brings extensive expertise in pharmaceutical development and regulatory approvals, previously served as Product Development Lead at Sanofi and held director roles at WuXi AppTec. His educational background includes a Ph.D. in Applied Biological Sciences and a Project Management Professional certification. Forest Hills Lab aims to advance its clinical stage biopharmaceutical platform, which focuses on developing therapies for neurodegenerative diseases. Mstone Partners, an incubator of biotech, healthcare, and AI companies, is the largest shareholder of Forest Hills Lab.
Sectors
- Life Sciences
- Biopharmaceuticals
Geography
- United States – The article mentions Paramus, NJ as the location of Forest Hills Lab.
Industry
- Life Sciences – The article discusses Forest Hills Lab, a life sciences company focusing on regenerative medicine and medical aesthetics.
- Biopharmaceuticals – Forest Hills Lab is developing therapies for neurological conditions and is advancing its biopharmaceutical platform.
Financials
Participants
Name | Role | Type | Description |
---|---|---|---|
Forest Hills Lab | Target Company | Company | An innovative global life sciences company focused on regenerative medicine and medical aesthetics. |
Eddy Zhu | Chief CMC Officer | Person | New appointee at Forest Hills Lab with extensive experience in pharmaceutical development and regulatory approvals. |
Mstone Partners | Largest Shareholder | Company | An incubator of biotech, healthcare, and AI companies, supporting Forest Hills Lab. |
Alex Yang | Chair and Chief Executive Officer | Person | CEO of Forest Hills Lab, commenting on Eddy Zhu's appointment. |
Sanofi | Previous Employer | Company | Dr. Eddy Zhu's most recent employer, where he served as Product Development Lead. |
WuXi AppTec | Previous Employer | Company | Company where Dr. Zhu served as a director for the Parenteral Drug Development Team. |